| | | | | |
Company | IBL-America | IBL-America | IBL-America | IBL-America | IBL-America |
Item | Cyfra ELISA Assay | Amyloid Beta (1-40) ELISA Assay | Anti-Tocilizumab (Actemra®) ELISA | Anti-Ustekinumab (Stelara®) ELISA | IGF-2 RIA Assay |
Citations | | | | | |
Catalog Number | 211-10 | 27713 | TM09021 | TM09036 | IGF-R30 |
Price | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |
Description | Solid phase, non-competitive immunoassay (ELISA) for the determination of soluble cytokeratin 19 fragments in human serum. 510(k) cleared, can be used in diagnostic procedures. | Solid phase sandwich ELISA for the determination of human Aß(1-40) in EDTA-plasma, cerebrospinal fluids, serum, cell culture media or the extract from brain tissue. For research use only, not for use in diagnostic procedures. | Enzyme immunoassay (ELISA) test kit for the determination of free antibodies directed against the drug Tocilizumab (Actemra®) in serum and plasma. For research use only, not for use in diagnostic procedures. | The ImmunoGuide Antibody to Ustekinumab ELISA kit has been designed for the measurement of free antibodies against this drug. It does not detect such antibodies which already are bound to the drug. | Radioimmunoassay for the determination of human IGF-II in serum or plasma. For research use only, not for use in diagnostic procedures. |
Detection Target | Adrenaline / Noradrenaline / Dopamine | Anti-Rituximab (Rituxan®) | S100B | sAPP Total | HTGL |
Sample Type | Multiple | Serum and plasma. | Serum | Serum, Blood Plasma, CSF, Cell Culture Supernatant | Human serum, EDTA plasma and Postheparin plasma. |
Method | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Enzyme-Linked Immunosorbent Assay (ELISA) | Radio Immuno Assay (RIA) |
Detection Range | 1.4 to 47.6 ng/mL | 7.81 to 500 pg/mL | 0 / 6 to 200 ng/mL | Anti-Ustekinumab (Stelara®) | 0.4 to 50.0 ng/mL |
Sensitivity | Adrenaline: 0.25 ng/mL x C*; Noradrenaline: 0.1 ng/mL x C*; Dopamine 0.25 ng/mL x C*. Sensitivity based on calculated correction factor. | 40 ng/mL | Inquire | 0.06 ng/mL | 0.01 ng/mL |
Assay Time | 1 hr 45 mins (incubation) | Overnight + 1 hr 30 mins (incubation) | 2 hours, 10 min. total incubation time. | 2 hour, 30 min. total incubation time. | 49 hrs 30 mins (incubation) |
Get Quote | Supplier Page | Supplier Page | Supplier Page | Supplier Page | Supplier Page |